Sobre 2 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the full record of transactions filed by Kelly Timothy Edwin, Director Financiero. Insider active across 1 company, notably Praxis Precision Medicines, Inc.. Aggregated, 20 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €94k. History available since 31 August 2021. The latest transaction was disclosed on 12 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kelly Timothy Edwin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3905 títulos@ 19,48 US$15.1% de su flujoCommon StockSEC:0001689548-21-000083:0
Salida canónica: 29 nov 2021 (T+90)
20 de 20 declaraciones
About Kelly Timothy Edwin
Kelly Timothy Edwin is Chief Financial Officer at Praxis Precision Medicines, Inc. (XNAS). He has 20 filings in total, and across the 20 recent sampled filings observed between 2021-09-02 and 2026-01-13, buy transactions amount to EUR 93947, with no sells; the most frequent transaction nature is Attribution.